It's the Patented Medicines Prices Review Board, yes.
The second element is having the private insurers join the pCPA, the pharmaceutical alliance that currently is with governments. The reason for doing so is that it would allow all buyers to pool their full market power to negotiate lower prices, to bring prices down even further.
That was sort of one bucket.